Effects of the long-acting insulin analog insulin glargine on cultured human skeletal muscle cells: Comparisons to insulin and IGF-I

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 12, 2001, Pages 5838-5847

  Ciaraldi, T P ^a   Carter, L ^a   Seipke, G ^a   Mudaliar, S ^a   Henry, R R ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; INSULIN DERIVATIVE; INSULIN GLARGINE; IODINE 125; LIGAND; SOMATOMEDIN C; THYMIDINE;

ADULT; ARTICLE; BINDING SITE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN SENSITIVITY; LIGAND BINDING; METABOLISM; MITOGENESIS; MUSCLE CELL; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN BINDING; SKELETAL MUSCLE;

EID: 0035215941     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.86.12.8110     Document Type: Article

References (47)

1. Long-acting insulin analogs
2. Genetically engineered insulin analogs: Diabetes in the new millenium
3. Insulin lispro (HUmalog), a novel fast-acting insulin analogue for the treatment of diabetes mellitus: Overview of pharmacological and clinical data
4. A superactive insulin: [B10-aspartic acid]insulin (human)
5. An insulin analogue possessing higher in vitro biological activity than receptor binding affinity. [21-proline-B]insulin
6. Characteristics of binding of a low affinity, noncooperative insulin ([leuB25]insulin) to IM-9 lymphocytes
7. Effects of modified insulin B21-B26 fragments on glycogenolysis and on insulin-receptor complex fate in cultured fetal hepatocytes
8. Binding of mutant insulins to a mutated insulin receptor
9. Insulin glargine
10. The long acting human insulin analog HOE 901: Characteristics of insulin signaling in comparison to Asp(B10) and regular insulin
11. Modifications in the B10 and B26-30 regions of the B chain of human insulin alter affinity for the human IGF-I receptor more than for the insulin receptor
12. Binding and biological effects of insulin, insulin analogues and insulin-like growth factors in rata aortic smooth muscle cells. Comparison of maximal promoting activities
13. Growth promoting and metabolic activity of the human insulin analogue [GlyA21, ArgB31, ArgB32]insulin (HOE 901) in muscle cells
14. Correlations of receptor binding and metabolic and mitogenig potencies of insulin analogs designed for clinical use
15. Insulin action and glucose metabolism in non-diabetic control and NIDDM subjects: Comparison using human skeletal muscle cell cultures
16. Glycogen synthase activity is reduced in cultured skeletal muscle cells of non-insulin-dependent diabetes mellitus subjects
17. Glucose transport in cultured human skeletal muscle cells. Regulation by insulin and glucose in nondiabetic and non-insulin-dependent diabetes mellitus subjects
18. Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin dependent (Type II) diabetes independent of impaired glucose uptake
19. Multiple defects in muscle glycogen synthase activity contribute to reduced glycogen synthesis in non-insulin dependent diabetes mellitus
20. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
21. Insulin signal transduction by a mutant human insulin receptor lacking the NPEY sequence
22. "Western blotting" electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A
23. 125I-insulin in adipocytes and IM-9 lymphocytes
24. Mechanisms and consequences of activation of protein kinase B/Akt
25. Phosphatidylinositol-3 kinase dependent pathways: The role in control of cell growth, survival, and malignant transformation
26. New insights into the control of MAP kinase pathways
27. Regulation of MAP kinase pathway activity in vivo in human skeletal muscle
28. Involvement of phosphoinosotide 3-kinase in insulin stimulation of MAP-kinase and phosphorylation of protein kinase-B in human skeletal muscle: Implications for glucose metabolism
29. Diabetes due to secretion of a structurally abnormal insulin (insulin Wakayama)
30. Decreased biologic activity and degradation of human [serB24]-insulin, a second mutant insulin
31. Interaction between the A2 and A19 amino acid residues is of critical importance for high biological activity in insulin: [19-leucine-Alinsulin
32. Studies on growth-promoting action of insulin: Mitogenic activity of insulin and its analogues in mouse mammary tumor cells
33. Biological activity in vivo of insulin analogues modified in the N-terminal region of the B-chain
34. Insulin-like growth factor I binding and receptor kinase in red and white muscle
35. Skeletal muscle cell-derived insulin-like growth factor (IGF) binding proteins inhibit IGF-I-induced myogenesis in rat L6E9 cells
36. Effects of cytokines on insulin-like growth factor-binding protein secretion by muscle cells in vitro
37. Insulin-like growth factor binding proteins
38. Characterization of insulin-like growth factor receptors in rat anterior pituitary, hypothalamus and brain
39. Receptors for insulin-like growth factors and growth effects of multiplication-stimulating activity (rat insulin-like growth factor II) in rat embryo fibroblasts
40. Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor
41. Logical analysis of timing-dependent receptor signalling specificity: Application to the insulin receptor metabolic and mitogenic signalling pathways
42. Timing-dependence of insulin receptor mitogenic versus metabolic signalling: A plausible model based on coincidence of hormone and effector binding
43. Sustained signalling from the insulin receptor after stimulation with insulin analogues exhibiting increased mitogenic potency
44. Does mitogen-activated-protein kinase have a rote in insulin action
45. Mitogen activated protein kinase activation is not sufficient for stimulation of glucose transport or glycogen synthase in 3T3-L1 adipocytes
46. Expression of a constitutively active Akt ser.thr kinase in 3T3-L1 adxipocytes stimulates glucose uptake and glucose transporter 4 translocation
47. Potential role of protein kinase B in insulin-induced glucose transport, glycogen synthesis, and protein synthesis